A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults

Conditions: Respiratory Syncytial Virus Infections Interventions: Biological: STR-V003/Placebo Sponsors: Starna Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials